(Q34590091)

English

First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial

scientific article

Statements

First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial (English)
Anton Hagenbeek
Ole Gadeberg
Peter Johnson
Lars Møller Pedersen
Brian K Link
Michael Kneba
Andreas Engert
Mimi Flensburg
Jørgen Petersen
Nedjad Losic
John Radford
5486-5495

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit